{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:14:25Z","timestamp":1648779265958},"reference-count":169,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2000,6]]},"DOI":"10.1053\/bega.2000.0085","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T13:54:50Z","timestamp":1032443690000},"page":"365-390","source":"Crossref","is-referenced-by-count":4,"title":["Drug treatment for bleeding oesophageal varices"],"prefix":"10.1053","volume":"14","author":[{"given":"Lucy","family":"Dagher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Patch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Burroughs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/bega.2000.0085_RF1","first-page":"1081","article-title":"Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension","volume":"92","author":"Grace","year":"1997","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2000.0085_RF2","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM198810133191505","volume":"319","year":"1988","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0085_RF3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/hep.1840220145","article-title":"The treatment of portal hypertension: a meta-analytic review","volume":"22","author":"D'Amico","year":"1995","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2307\/2531052","article-title":"Estimators of the Mantel\u2013Haenszel variance constant in both sparse data and large strata limiting models","volume":"42","author":"Robbins","year":"1986","journal-title":"Biometrics"},{"key":"10.1053\/bega.2000.0085_RF5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"Der Simonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1053\/bega.2000.0085_RF6","doi-asserted-by":"crossref","first-page":"565","DOI":"10.7326\/0003-4819-96-5-565","article-title":"Continuous intravenous vasopressin in active upper gastrointestinal bleeding: a placebo controlled trial","volume":"96","author":"Fogel","year":"1982","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/bega.2000.0085_RF7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1056\/NEJM196201182660307","article-title":"Effect of intravenously administered posterior pituitary extract on haemorrhage from bleeding oesophageal varices","volume":"266","author":"Merigan","year":"1962","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0085_RF8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0016-5085(75)80001-1","article-title":"Intraarterial vasopressin in the treatment of upper gastrointestinal hemorrhage: a prospective, controlled clinical trial","volume":"68","author":"Conn","year":"1975","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0085_RF9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/archsurg.1980.01380010022004","article-title":"Selective intraarterial vasopressin infusion for upper gastrointestinal tract hemorrhage: a controlled trial","volume":"115","author":"Mallory","year":"1980","journal-title":"Archives of Surgery"},{"key":"10.1053\/bega.2000.0085_RF10","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/hep.1840100612","article-title":"Association of transdermal nitroglycerin to vasopressin infusion in the treatment of variceal hemorrhage: a placebo controlled clinical trial","volume":"10","author":"Bosch","year":"1989","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF11","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/hep.1840060313","article-title":"Controlled trial of vasopressin plus nitroglycerin vs vasopressin alone in the treatment of bleeding esophageal varices","volume":"6","author":"Tsai","year":"1986","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF12","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/hep.1840060314","article-title":"A randomised trial of vasopressin and vasopressin plus nitroglycerin in the control of acute variceal hemorrhage","volume":"6","author":"Gimson","year":"1986","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/hep.1840060121","article-title":"Terlipressin in bleeding esophageal varices: a placebo-controlled, double-blind study","volume":"6","author":"Walker","year":"1986","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00004836-198902000-00014","article-title":"Placebo controlled trial of terlipressin (glypressin) in the management of acute variceal bleeding","volume":"11","author":"Freeman","year":"1989","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1053\/bega.2000.0085_RF15","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3109\/00365529009095539","article-title":"Terlipressin (triglycyl-lysine vasopressin) controls acute bleeding oesophageal varices. A double-blind, randomized, placebo-controlled trial","volume":"25","author":"Soderlund","year":"1990","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1053\/bega.2000.0085_RF16","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0140-6736(95)92708-5","article-title":"Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients","volume":"346","author":"Levacher","year":"1995","journal-title":"Lancet"},{"key":"10.1053\/bega.2000.0085_RF17","first-page":"62","article-title":"Controlled trial of terlipressin (\u2018glypressin\u2019) versus vasopressin in the early treatment of esophageal varices","volume":"2","author":"Freeman","year":"1982","journal-title":"Lancet"},{"key":"10.1053\/bega.2000.0085_RF18","series-title":"Vasopressin Analogs and Portal Hypertension","first-page":"155","article-title":"A randomized trial of triglycyl-lysine vasopressin versus lysine vasopressin in active cirrhotic variceal hemorrhage","author":"Desaint","year":"1987"},{"key":"10.1053\/bega.2000.0085_RF19","first-page":"131","article-title":"A randomized controlled study of triglycyl-vasopressin and vasopressin plus nitroglycerin in the control of acute esophageal variceal hemorrhage","volume":"5","author":"Lee","year":"1988","journal-title":"Chinese Journal of Gastroenterology"},{"key":"10.1053\/bega.2000.0085_RF20","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1440-1746.1990.tb01439.x","article-title":"A controlled study of glypressin versus vasopressin in the control of bleeding from esophageal varices","volume":"5","author":"Chiu","year":"1988","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.2000.0085_RF21","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0168-8278(05)80059-5","article-title":"Teripressin or vasopressin plus transdermal nitroglycerin in a treatment strategy for digestive bleeding in cirrhosis. A randomized clinical trial","volume":"20","author":"D'Amico","year":"1994","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0085_RF22","series-title":"Vasopressin Analogs and Portal Hypertension","first-page":"149","article-title":"Prospective comparison of glypressin, tamponade and their association in the treatment of bleeding esophageal varices","author":"Colin","year":"1987"},{"key":"10.1053\/bega.2000.0085_RF23","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/hep.1840110423","article-title":"A randomized trial of terlipressin plus nitroglycerin vs balloon tamponade in the control of acute variceal haemorrhage","volume":"11","author":"Fort","year":"1990","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF24","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1016\/S0168-8278(05)81159-6","article-title":"Balloon tamponade with Linton\u2013Michel tube versus terlipressin in the treatment of acute oesophageal and gastric variceal bleeding","volume":"21","author":"Blanc","year":"1994","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0085_RF25","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJM199106203242505","volume":"324","year":"1991","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0085_RF26","first-page":"207A","article-title":"Sclerotherapy alone vs sclerotherapy plus terlipressin vs sclerotherapy plus octreotide in the treatmetn of acute variceal haemorrhage","volume":"24","author":"Brunati","year":"1996","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF27","first-page":"5226","article-title":"Effect of somatostatin on splanchnic haemodynamics","volume":"80","author":"Sonneburg","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0085_RF28","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/0016-5085(81)90014-7","article-title":"Effects of somatostatin on hepatic and systemic haemodynamics in patients with cirrhosis of the liver: comparison with vasopressin","volume":"80","author":"Bosch","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0085_RF29","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0168-8278(98)80259-6","article-title":"Randomized controlled trial of sclerotherapy vs somatostatin infusion in the prevention of early rebleeding following variceal hemorrhage in patients with cirrhosis","volume":"29","author":"Escorsell","year":"1998","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0085_RF30","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/hep.1840100611","article-title":"A multicenter, randomized, double-blind trial of somatostatin in the management of acute hemorrhage from esophageal varices","volume":"10","author":"Valenzuela","year":"1989","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF31","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/0016-5085(90)91166-4","article-title":"Randomised, double-blind, placebo-controlled trial of somatostatin for variceal bleeding","volume":"99","author":"Burroughs","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0085_RF32","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1136\/bmj.310.6993.1495","article-title":"Somatostatin vs placebo in bleeding esophageal-varices\u2014randomized trial and metaanalysis","volume":"310","author":"Gotzsche","year":"1995","journal-title":"British Medical Journal"},{"key":"10.1053\/bega.2000.0085_RF33","first-page":"411","article-title":"Massive upper digestive hemorrhage in portal hypertension. Results of a controlled study","volume":"70","author":"Flati","year":"1986","journal-title":"Revista Espanola de Enfermedades del Aparato Digestivo"},{"key":"10.1053\/bega.2000.0085_RF34","first-page":"759","article-title":"Comparison of somatostatin and cimetidine in the treatment of acute esophageal variceal bleeding","volume":"39","author":"Testoni","year":"1986","journal-title":"Current Therapy and Research"},{"key":"10.1053\/bega.2000.0085_RF35","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/hep.1840040315","article-title":"Comparison of intravenous somatostatin and vasopressin infusion in treatment of acute variceal hemorrhage","volume":"4","author":"Kravetz","year":"1984","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF36","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/bmj.290.6464.275","article-title":"A prospective randomised controlled clinical trial comparing somatostatin and vasopressin in controlling acute variceal haemorrhage","volume":"290","author":"Jenkins","year":"1985","journal-title":"British Medical Journal"},{"key":"10.1053\/bega.2000.0085_RF37","first-page":"21","article-title":"Effect of somatostatin in controlling bleeding from esophageal varices","volume":"17","author":"Bagarani","year":"1987","journal-title":"Italian Journal of Surgical Science"},{"key":"10.1053\/bega.2000.0085_RF38","first-page":"71","article-title":"Comparison of somatostatin and vasopressin in the control of acute esophageal variceal hemorrhage. A randomized, controlled study","volume":"7","author":"Hsia","year":"1990","journal-title":"Chinese Journal of Gastroenterology"},{"key":"10.1053\/bega.2000.0085_RF39","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1016\/0168-8278(91)91621-M","article-title":"A randomized trial of somatostatin vs vasopressin plus nitroglycerin in the treatment of acute variceal bleeding","volume":"13","author":"Rodriguez-Moreno","year":"1991","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0085_RF40","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1053\/gast.1996.v111.pm8898643","article-title":"Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage","volume":"111","author":"Feu","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0085_RF41","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0168-8278(91)90917-Z","article-title":"Somatostatin versus Sengstaken tube balloon tamponade for primary hemostasis of bleeding esophageal varices: a randomised pilot study","volume":"12","author":"Jaramillo","year":"1991","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0085_RF42","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0168-8278(91)90867-B","article-title":"A prospective randomised trial comparing somatostatin, balloon tamponade and the combination of both methods in the management of acute variceal haemorrhage","volume":"13","author":"Averignos","year":"1991","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0085_RF43","first-page":"583A","article-title":"Somatostatin (SMS) and urgent sclerotherapy (US) in active oesophageal variceal bleeding","volume":"98","author":"Di Febo","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0085_RF44","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0168-8278(05)80105-9","article-title":"A prospective randomized controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding esophageal-varices","volume":"16","author":"Shields","year":"1992","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0085_RF45","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/hep.1840200216","article-title":"A prospective randomised trial comparing somatostatin and sclerotherapy in the treatment of acute variceal bleeding","volume":"20","author":"Planas","year":"1994","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF46","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(97)05099-X","article-title":"Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial","volume":"350","author":"Averignos","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/bega.2000.0085_RF47","first-page":"1326A","article-title":"Sclerotherapy with or without somatostatin or octreotide in the treatment of acute variceal haemorrhage: our experience","volume":"110","author":"Signorelli","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0085_RF48","first-page":"48","article-title":"The effects of somatostatin and SMS 201-995 on hepatic haemodynamics in patients with cirrhosis and portal hypertension","volume":"2","author":"Jenkins","year":"1988","journal-title":"Fibrinolisis"},{"key":"10.1053\/bega.2000.0085_RF49","first-page":"489","article-title":"Octreotide reduces azygous blood flow in cirrhotic patients with portal hypertension","volume":"2","author":"McCormick","year":"1990","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.2000.0085_RF50","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000200264","article-title":"A study of octreotide in oesophageal varices","volume":"45","author":"McKee","year":"1990","journal-title":"Digestion"},{"key":"10.1053\/bega.2000.0085_RF51","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0168-8278(05)80663-4","article-title":"A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding","volume":"16","author":"Hwang","year":"1992","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0085_RF52","first-page":"61","article-title":"Terlipressin plus transdermal nitroglycerin vs octreotide in the control of acute bleeding from esophageal-varices\u2014a multicenter randomized trial","volume":"18","author":"Silvain","year":"1993","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF53","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0140-6736(93)91758-E","article-title":"Octreotide infusion or emergency sclerotherapy for variceal hemorrhage","volume":"342","author":"Sung","year":"1993","journal-title":"Lancet"},{"key":"10.1053\/bega.2000.0085_RF54","first-page":"1297A","article-title":"Octreotide versus emergency sclerotherapy in acute variceal haemorrhage in liver cirrhosis","volume":"110","author":"Poo","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0085_RF55","first-page":"206A","article-title":"Octreotide vs sclerotherapy in the treatment of acute variceal bleeding","volume":"96","author":"Kravetz","year":"1996","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF56","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.41.4.526","article-title":"A multicentre randomised trial comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal haemorrhage","volume":"41","author":"Jenkins","year":"1997","journal-title":"Gut"},{"key":"10.1053\/bega.2000.0085_RF57","first-page":"533A","article-title":"Octreotide vs. sclerotherapy in the control of acute variceal bleeding in schistosomal portal hypertension: a randomized trial","volume":"28","author":"El-Jackie","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF58","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJM199508313330904","article-title":"Sclerotherapy with or without octreotide for acute variceal bleeding","volume":"333","author":"Besson","year":"1995","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0085_RF59","first-page":"1326A","article-title":"Esophageal varices bleeding: comparison between treatment with sclerotherapy alone vs sclerotherapy plus octreotide","volume":"26","author":"Signorelli","year":"1997","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF60","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/S0140-6736(95)92840-5","article-title":"Prospective randomised study of effect of octreotide on rebleeding from esophageal varices after endoscopic ligation","volume":"346","author":"Sung","year":"1995","journal-title":"Lancet"},{"key":"10.1053\/bega.2000.0085_RF61","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/hep.510240344","article-title":"Therapeutic benefit of vaso-active drugs for acute variceal bleeding: a real pharmacological effect, or a side-effect of definitions in trials?","volume":"24","author":"Burroughs","year":"1996","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF62","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/hep.510240344","article-title":"International Octreotide Varices Study Group. Double blind RCT of 5 day octreotide versus placebo, associated with sclerotherapy for trial failures","volume":"24","author":"Burroughs","year":"1996","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF63","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/0270-9139(95)90054-3","article-title":"Sclerotherapy plus octreotide versus sclerotherapy alone in the prevention of early rebleeding from esophageal-varices\u2014a randomized, double-blind, placebo-controlled, multicenter trial","volume":"21","author":"Primignani","year":"1995","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF64","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/hep.510280507","article-title":"Octreotide compared with placebo in a treatment strategy for early rebleeding in cirrhosis: a double blind, randomized pragmatic trial","volume":"28","author":"D'Amico","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF65","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/0016-5085(95)90146-9","article-title":"Prognostic significance of bacterial infections in bleeding cirrhotic patients: a prospective study","volume":"108","author":"Bernard","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0085_RF66","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/hep.510270504","article-title":"Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage","volume":"27","author":"Goulis","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF67","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/hep.510290608","article-title":"Antibiotic prophylaxis (AbP) for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding (GB): a meta-analysis","volume":"29","author":"Bernard","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF68","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/hep.510280339","article-title":"Portal hypertension and variceal bleeding: an AASLD single topic symposium","volume":"28","author":"Grace","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF69","series-title":"Portal Hypertension: Pathophysiology and Treatment","first-page":"72","article-title":"Portal hypertension in cirrhosis: natural history","author":"Pagliaro","year":"1994"},{"key":"10.1053\/bega.2000.0085_RF70","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1053\/gast.1996.v111.pm8780575","article-title":"Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study","volume":"111","author":"Vorobioff","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0085_RF71","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/0016-5085(90)91168-6","article-title":"Hemodynamic events in a prospective randomized trial of propranol versus placebo in the prevention of the 1st variceal hemorrhage","volume":"99","author":"Groszmann","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0085_RF72","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0140-6736(95)91740-3","article-title":"Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal hemorrhage in patients with cirrhosis","volume":"346","author":"Feu","year":"1995","journal-title":"Lancet"},{"key":"10.1053\/bega.2000.0085_RF73","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0168-8278(98)80351-6","article-title":"Clinical versus haemodynamic response to drugs in portal hypertension","volume":"28","author":"McCormick","year":"1998","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0085_RF74","first-page":"A10","article-title":"Propranolol et prevention des recidives de rupture de varice oesophagienne du cirrhotique","volume":"18","author":"Cerbelaud","year":"1986","journal-title":"Gastroenterologie Clinique et Biologique"},{"key":"10.1053\/bega.2000.0085_RF75","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJM198312223092502","article-title":"Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis","volume":"309","author":"Burroughs","year":"1983","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0085_RF76","first-page":"1395A","article-title":"Propranolol in the prevention of variceal hemorrhage in alcoholic cirrhotic patients","volume":"8","author":"Colman","year":"1990","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF77","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/hep.1840090315","article-title":"Beta-blockade prevents recurrent gastrointestinal-bleeding in well-compensated patients with alcoholic cirrhosis\u2014a multicenter randomized controlled trial","volume":"9","author":"Colombo","year":"1989","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF78","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0016-5085(90)91308-S","article-title":"Propranolol in the prevention of recurrent variceal hemorrhage in cirrhotic-patients\u2014a controlled trial","volume":"98","author":"Garden","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0085_RF79","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000199483","article-title":"Nadolol for prevention of variceal rebleeding in cirrhosis\u2014a controlled clinical-trial","volume":"37","author":"Gatta","year":"1987","journal-title":"Digestion"},{"key":"10.1053\/bega.2000.0085_RF80","first-page":"507","article-title":"Unsichere rezidivprophylaxe von osophagusvarizenblutungen durch Propranolol bei Leberzirrhotikern: eine prospektive kontrolliertr studie","volume":"42","author":"Kobe","year":"1987","journal-title":"Zeitschrift Fur Klinische Medizin-Zkm"},{"key":"10.1053\/bega.2000.0085_RF81","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/hep.1840040301","article-title":"A randomized controlled-study of propranolol for prevention of recurrent gastrointestinal-bleeding in patients with cirrhosis\u2014a final report","volume":"4","author":"Lebrec","year":"1984","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF82","first-page":"41","article-title":"Controlled trial of propranolol for the prevention of recurrent gastrointestinal-bleeding in patients with cirrhosis","volume":"11","author":"Queuniet","year":"1987","journal-title":"Gastroenterologie Clinique et Biologique"},{"key":"10.1053\/bega.2000.0085_RF83","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0168-8278(91)90828-Y","article-title":"Prevention of recurrent variceal bleeding in alcoholic cirrhotic-patients\u2014prospective controlled trial of propranolol and sclerotherapy","volume":"12","author":"Rossi","year":"1991","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0085_RF84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0676.1989.tb00370.x","article-title":"Randomized controlled-study of propranolol for prevention of recurrent esophageal-varices bleeding in patients with cirrhosis","volume":"9","author":"Sheen","year":"1989","journal-title":"Liver"},{"key":"10.1053\/bega.2000.0085_RF85","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/hep.1840060602","article-title":"Propranolol for the prevention of recurrent variceal hemorrhage\u2014a controlled trial","volume":"6","author":"Villeneuve","year":"1986","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF86","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/hep.510250112","article-title":"Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis","volume":"25","author":"Bernard","year":"1997","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF87","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/hep.1840110213","article-title":"Evaluation of molsidomine\u2014a vasodilator with antianginal properties in patients with alcoholic cirrhosis","volume":"11","author":"Vinel","year":"1990","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF88","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/hep.1840090114","article-title":"Long term hemodynamic effects of ketanserin, a 5-hydroxytryptamine blocker in portal hypertensive patients","volume":"6","author":"Vorobioff","year":"1989","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF89","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/hep.510230517","article-title":"The effect of long-term treatment with spironolactone on variceal pressure in patients with portal hypertension without ascites","volume":"23","author":"Nevens","year":"1996","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF90","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0168-8278(88)80480-X","article-title":"Propranolol or endoscopic sclerotherapy in the prevention of recurrence of variceal bleeding\u2014a prospective, randomized controlled trial","volume":"7","author":"Alexandrino","year":"1988","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0085_RF91","first-page":"A215","article-title":"Efficacite compar\u00e9e du propranolol et des scleroses endoscopiques du varices oesophagiennes dans la prevention des recidives d'hemorragies digestives au cours des cirrhoces. Etude controlee","volume":"15 (supplement 2)","author":"Andreani","year":"1991","journal-title":"Gastroenterologie Clinique et Biologique"},{"key":"10.1053\/bega.2000.0085_RF92","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/hep.1840160116","article-title":"A prospective randomized trial comparing repeated endoscopic sclerotherapy and propranolol in decompensated (Child class-b and class-c) cirrhotic-patients","volume":"16","author":"Dasarathy","year":"1992","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF93","first-page":"234","article-title":"Endoscopic sclerotherapy versus oral propranolol after variceal hemorrhage in cirrhosis\u2014results of a 4-year prospective randomized trial","volume":"12","author":"Dollet","year":"1988","journal-title":"Gastroenterologie Clinique et Biologique"},{"key":"10.1053\/bega.2000.0085_RF94","first-page":"1220","article-title":"Final analysis of a randomized trial of propranolol (P) vs sclerotherapy (Eps) for the prevention of recurrent variceal hemorrhage in cirrhosis","volume":"8","author":"Fleig","year":"1988","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF95","series-title":"Gastroenterology World Congress Abstract Book","article-title":"Endoscopic injection sclerotherapy and propranolol in the prevention of recurrent variceal bleeding","author":"Liu","year":"1990"},{"key":"10.1053\/bega.2000.0085_RF96","first-page":"833","article-title":"Prevention of recurrent bleeding in patients with cirrhosis\u2014results of a controlled trial of propranolol versus endoscopic sclerotherapy","volume":"15","author":"Martin","year":"1991","journal-title":"Gastroenterologie Clinique et Biologique"},{"key":"10.1053\/bega.2000.0085_RF97","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1016\/S0168-8278(87)80500-7","article-title":"Endoscopic sclerotherapy (Es) Vs propranolol (Pr) in the elective treatment of variceal bleeding\u2014preliminary-results of a randomized controlled clinical-trial","volume":"5","author":"Teres","year":"1987","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0085_RF98","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hep.1840110304","article-title":"A controlled trial of oral propranolol compared with injection sclerotherapy for the long-term management of variceal bleeding","volume":"11","author":"Westaby","year":"1990","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF99","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1056\/NEJM199606203342502","article-title":"Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding","volume":"334","author":"Villanueva","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0085_RF100","article-title":"Endoscopic ligation versus nadolol plus isosorbide-5-mononitrate for the prevention of variceal rebleeding. A prospective randomized trial","volume":"30","author":"Minyana","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF101","series-title":"Gut","article-title":"A randomised controlled trial comparing wedge pressure guided medical therapy (MT) against variceal bleeding (VB) in the secondary prevention of variceal haemorrhage","author":"Patch","year":"2000"},{"key":"10.1053\/bega.2000.0085_RF102","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/hep.1840060422","article-title":"Use of propranolol to reduce the rebleeding rate during injection sclerotherapy prior to variceal obliteration","volume":"6","author":"Westaby","year":"1986","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF103","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/00365528909093057","article-title":"Propranolol in prevention of rebleeding from esophageal-varices during the course of endoscopic sclerotherapy","volume":"24","author":"Jensen","year":"1989","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1053\/bega.2000.0085_RF104","first-page":"711","article-title":"Evaluation of propranolol for prevention of recurrent bleeding from esophageal-varices between sclerotherapy sessions","volume":"156","author":"Lundell","year":"1990","journal-title":"Acta Chirurgica Scandinavica"},{"key":"10.1053\/bega.2000.0085_RF105","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/0016-5085(92)91740-U","article-title":"Propranolol reduces the rebleeding rate during endoscopic sclerotherapy before variceal obliteration","volume":"102","author":"Vinel","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0085_RF106","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0168-8278(05)80586-0","article-title":"Propranolol in the prevention of recurrent upper gasatrointestinal-bleeding in patients with cirrhosis undergoing endoscopic sclerotherapy\u2014a randomized controlled trial","volume":"19","author":"Avgerinos","year":"1993","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0085_RF107","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0168-8278(05)80585-9","article-title":"A prospective randomized study to evaluate propranolol in patients undergoing long-term endoscopic sclerotherapy","volume":"19","author":"Acharya","year":"1993","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0085_RF108","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0168-8278(94)80141-X","article-title":"Prevention of rebleeding from esophageal-varices\u20142-year follow-up of a prospective controlled trial of propranolol in addition to sclerotherapy","volume":"21","author":"Vickers","year":"1994","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0085_RF109","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/gut.38.5.770","article-title":"Sclerotherapy versus sclerotherapy and propranolol in the prevention of rebleeding from oesophageal varices: a randomised study","volume":"38","author":"El-Sayed","year":"1996","journal-title":"Gut"},{"key":"10.1053\/bega.2000.0085_RF110","first-page":"364","article-title":"Nadolol for prevention of variceal rebleeding during the course of endoscopic injection sclerotherapy\u2014a randomized pilot-study","volume":"12","author":"Bertoni","year":"1990","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1053\/bega.2000.0085_RF111","first-page":"988","article-title":"Nadolol does not reduce early rebleeding in cirrhotics undergoing endoscopic variceal sclerotherapy (Evs)\u2014a multicenter randomized controlled trial","volume":"12","author":"Gerunda","year":"1990","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF112","first-page":"499","article-title":"Nadolol as an adjuvant to sclerotherapy of esophageal varices for prevention of recurrent hemorrhaging","volume":"86","author":"Villanueva","year":"1994","journal-title":"Revista Espanola de Enfermedades Digestivas"},{"key":"10.1053\/bega.2000.0085_RF113","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/00365529409094851","article-title":"Oral isosorbide-5-mononitrate reduces the rebleeding rate during the course of injection sclerotherapy for esophageal-varices","volume":"29","author":"Bertoni","year":"1994","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1053\/bega.2000.0085_RF114","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/0140-6736(91)93125-S","article-title":"Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis","volume":"337","author":"Perezayuso","year":"1991","journal-title":"Lancet"},{"key":"10.1053\/bega.2000.0085_RF115","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/hep.1840120624","article-title":"Preventive therapy of 1st gastrointestinal bleeding in patients with cirrhosis\u2014results of controlled trial comparing propranolol, endoscopic sclerotherapy and placebo","volume":"12","author":"Andreani","year":"1990","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF116","first-page":"1024","article-title":"Prophylaxis of 1st hemorrhage from esophageal varices by sclerotherapy, propranolol or both in cirrhotic patients\u2014a randomized multicentric trial","volume":"14","author":"Bendsten","year":"1991","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF117","first-page":"1395","article-title":"A randomized controlled trial for the prevention of the 1st upper gastrointestinal bleeding due to portal hypertension in cirrhosis\u2014sclerotherapy or propranolol versus control groups","volume":"8","author":"Strauss","year":"1988","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF118","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1056\/NEJM198710013171403","article-title":"Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices","volume":"317","author":"Pascal","year":"1987","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0085_RF119","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0168-8278(89)90078-0","article-title":"Propranolol prevents 1st gastrointestinal bleeding in non ascitic cirrhotics patients\u2014a final report of a multicenter randomized trial","volume":"9","author":"Pasta","year":"1989","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0085_RF120","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/hep.1840130517","article-title":"Propranolol in the prevention of the 1st hemorrhage from esophagogastric varices\u2014a multicenter randomized clinical trial","volume":"13","author":"Conn","year":"1991","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF121","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/hep.1840080103","article-title":"Nadolol can prevent the 1st gastrointestinal bleeding in cirrhotics\u2014a prospective, randomized study","volume":"8","author":"Ideo","year":"1988","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF122","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0168-8278(88)80515-4","article-title":"Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis\u2014a randomized trial","volume":"7","author":"Lebrec","year":"1988","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0085_RF123","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/00042737-199807000-00004","article-title":"A discussion of how terlipressin limits mortality in cases of bleeding oesophageal varices","volume":"10","author":"Lebrec","year":"1998","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.2000.0085_RF124","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJM199105303242202","article-title":"Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices\u2014an analysis of data and prognostic factors in 589 patients from four randomized clinical trials","volume":"324","author":"Poynard","year":"1991","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0085_RF125","first-page":"407","article-title":"Propranolol for the prevention of the 1st esophageal variceal hemorrhage\u2014a life time commitment","volume":"12","author":"Grace","year":"1990","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF126","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(96)05406-2","article-title":"Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'Ipertensione portale (GTIP)","volume":"348","author":"Merkel","year":"1996","journal-title":"Lancet"},{"key":"10.1053\/bega.2000.0085_RF127","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1053\/gast.1997.v113.pm9352866","article-title":"Effects of isosorbide-5-mononitrate compared with propranolol on first bleeding and long term survival in cirrhosis","volume":"113","author":"Angelico","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0085_RF128","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1046\/j.1440-1746.1999.01800.x","article-title":"Endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleed: preliminary report of a randomized controlled trial","volume":"14","author":"De","year":"1999","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.2000.0085_RF129","article-title":"Primary prophylaxis of variceal haemorrhage: a randomized controlled trial comparing band ligation, propranolol and isosorbide mononitrate","volume":"30","author":"Lui","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF130","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1056\/NEJM199904013401302","article-title":"Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding","volume":"340","author":"Sarin","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0085_RF131","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJM199904013401309","article-title":"Primary prevention of bleeding from esophageal varices","volume":"340","author":"Burroughs","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0085_RF132","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/hep.510250102","article-title":"The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin and nitric oxide","volume":"25","author":"Rockey","year":"1997","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF133","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/hep.510270141","article-title":"The hepatic circulation in health and disease: report of a single-topic symposium","volume":"27","author":"Shah","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF134","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/hep.510280308","article-title":"Beneficial hemodynamic effects of bosentan, a mixed ETa and ETb receptor antagonist, in portal hypertensive rats","volume":"28","author":"Sogni","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF135","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/hep.510280405","article-title":"Endothelial dysfunction in the intrahepatic microcirculation of the cirrhotic rat","volume":"28","author":"Gupta","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF136","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/0016-5085(93)90431-B","article-title":"Effects of low dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver","volume":"104","author":"Gentilini","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0085_RF137","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF02285088","article-title":"Portal pressure, renal function and hormonal profile after acute and chronic captopril treatment in cirrhosis","volume":"43","author":"Ibarra","year":"1992","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1053\/bega.2000.0085_RF138","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0016-5085(85)80088-3","article-title":"Acute effects of captopril on systemic and renal hemodynamic and on renal function in cirrhotic patients with ascites","volume":"88","author":"Pariente","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0085_RF139","first-page":"549","article-title":"Effect of enalapril treatment and sclerotherapy of esophageal varices on hepatic hemodynamics in portal hypertension","volume":"39","author":"Svoboda","year":"1992","journal-title":"Hepatogastroenterology"},{"key":"10.1053\/bega.2000.0085_RF140","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1440-1746.1995.tb01090.x","article-title":"Hemodynamic effects of enalaprilat on portal hypertension in patients with HBsAg-positive cirrhosis","volume":"10","author":"Chiang","year":"1995","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.2000.0085_RF141","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/hep.510290203","article-title":"Effect of Losartan, an angiotensin II receptor antagonist on portal pressure in cirrhosis","volume":"29","author":"Schneider","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF142","first-page":"219A","article-title":"Efficacy of Irbestartan, an angiotensin II receptor selective antagonist, in the treatment of portal hypertension","volume":"30","author":"Debernardi-Venon","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF143","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0016-5085(99)70472-5","article-title":"Angiotensin II receptor antagonist in the pharmacological therapy: a caution","volume":"117","author":"Garcia-Tsao","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0085_RF144","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0016-5085(95)90586-3","article-title":"Continuous prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function","volume":"109","author":"Albillos","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0085_RF145","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1056\/NEJM199812103392407","article-title":"Drug therapy: carvedilol","volume":"339","author":"Frishman","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0085_RF146","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0168-8278(96)80296-0","article-title":"Acute haemodynamic changes after oral carvedilol, a vasodilating beta-blocker, in patients with cirrhosis","volume":"25","author":"Forrest","year":"1996","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0085_RF147","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0168-8278(99)80108-1","article-title":"Acute and chronic haemodynamic and renal effects of carvedilol in patients with cirrhosis","volume":"30","author":"Stanley","year":"1999","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0085_RF148","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/hep.510300124","article-title":"Carvedilol, a new non-selective beta-blocker with intrinsic anti-alpha1 adrenergic activity, has a greater portal hypotensive effects than propranolol in patients with cirrhosis","volume":"30","author":"Banares","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF149","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0016-5085(92)91807-G","article-title":"Oral administration of clonidine in patients with alcoholic cirrhosis. Hemodynamic and liver function effects","volume":"102","author":"Albillos","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0085_RF150","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/0016-5085(92)90770-Y","article-title":"Long-term sympathetic and hemodynamic responses to clonidine in patients with cirrhosis and ascites","volume":"102","author":"Roulot","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0085_RF151","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(59)90755-X","article-title":"The effects of diuretics on portal venous pressure","volume":"2","author":"Atkinsons","year":"1959","journal-title":"Lancet"},{"key":"10.1053\/bega.2000.0085_RF152","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0168-8278(89)90058-5","article-title":"Reduction in portal pressure by acute administration of furosemide in patients with alcoholic cirrhosis","volume":"9","author":"Cereda","year":"1989","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0085_RF153","first-page":"46","article-title":"Reduction in hepatic vein pressure gradient as a consequence of volume contraction due to chronic administration of spironolactone in patients with cirrhosis and no ascites","volume":"86","author":"Okumura","year":"1991","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2000.0085_RF154","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/hep.1840190506","article-title":"Effects of low sodium diet and spironolactone on portal pressure in patients with compensated cirrhosis","volume":"19","author":"Garcia-Pagan","year":"1994","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF155","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1023\/A:1012993224326","article-title":"Chronic splanchnic hemodynamic effects of low dose transdermal nitroglycerin versus low-dose transdermal nitroglycerin plus spironolactone in patients with cirrhosis","volume":"42","author":"Sugano","year":"1997","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1053\/bega.2000.0085_RF156","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000139465","article-title":"The hemodynamic effect of AT-112, an analog of ketaserin, in portal hypertensive rats","volume":"54","author":"Lin","year":"1997","journal-title":"Pharmacology"},{"key":"10.1053\/bega.2000.0085_RF157","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/hep.1840070405","article-title":"Beneficial hemodynamic effects of ketanserin in patients with cirrhosis: possible role of serotonergic mechanism in portal hypertension","volume":"7","author":"Hadengue","year":"1987","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF158","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0016-5085(90)91302-M","article-title":"Ritanserin decreases portal pressure in conscious and unrestrained cirrhotic rats","volume":"98","author":"Mastai","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0085_RF159","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.1840140636","article-title":"Effects of ritanserin, a specific S2-serotoninergic antagonist, on portal pressure and splanchnic haemodynamics in portal hypertensive rats","volume":"14","author":"Nevens","year":"1991","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF160","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0140-6736(98)06020-6","article-title":"Bacterial infection in the pathogenesis of variceal bleeding","volume":"353","author":"Goulis","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/bega.2000.0085_RF161","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/hep.510300532","article-title":"Assessing the quality of randomized controlled trials: quality of design is not only the relevant variable","volume":"30","author":"Berck","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF162","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/hep.510300510","article-title":"Randomized clinical trials in hepatology: prediction of quality","volume":"30","author":"Kjaergard","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF163","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0168-8278(96)80127-9","article-title":"Developing consensus in portal hypertension","volume":"25","author":"de Franchis","year":"1996","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0085_RF164","first-page":"249A","volume":"26","year":"1997","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0085_RF165","first-page":"82","article-title":"Somatostatin in the treatment of hemorrhagic esophagogastric varices. Controlled clinical trial in comparison with ranitidine","volume":"78","author":"Loperfido","year":"1987","journal-title":"Recenti Progressi in Medicina"},{"key":"10.1053\/bega.2000.0085_RF166","first-page":"30","article-title":"Efficacia terapeutica de la somatostatina versus vasopressina mas nitroglycerina en la hemorragia activa por varices esofagogastrica","volume":"12","author":"Cardona","year":"1989","journal-title":"Gastroenterology and Hepatology"},{"key":"10.1053\/bega.2000.0085_RF167","first-page":"804","article-title":"Comparison of somatostatin and vasopressin in bleeding esophageal varices","volume":"85","author":"Saari","year":"1990","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2000.0085_RF168","first-page":"692","article-title":"Terlipressin (glypressin) versus somatostatin in the treatment of bleeding esophageal varices\u2014final report of a placebo-controlled, double-blind study","volume":"34","author":"Walker","year":"1996","journal-title":"Zeitschrift f\u00fcr Gastroenterologie"},{"key":"10.1053\/bega.2000.0085_RF169","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0016-5107(99)70039-8","article-title":"Gastric variceal ligation: a new technique","volume":"49","author":"Shiha","year":"1999","journal-title":"Gastrointestinal Endoscopy"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691800900854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691800900854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,16]],"date-time":"2021-05-16T05:31:39Z","timestamp":1621143099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691800900854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":169,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["S1521691800900854"],"URL":"https:\/\/doi.org\/10.1053\/bega.2000.0085","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2000,6]]}}}